• 140 Hits
  • Search Condition : Filter (MeSH = K562 Cells)
Species Resource Title
Human and Animal Cells HEL The acetylglucosaminyltransferase GnT-Ⅲ regulates erythroid differentiation through ERK/MAPK signaling.
Human and Animal Cells KG-1(RCB1166) , K562(RCB0027) The combination of venetoclax and quercetin exerts a cytotoxic effect on acute myeloid leukemia.
Human and Animal Cells HUDEP-2(RCB4557) Upregulation of miR‑6747‑3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‑thalassemia.
Human and Animal Cells K562(RCB0027) Linkage-Editing of Melibiosamine: Synthesis and Biological Evaluation of CH2- and CHF-Linked Analogs.
DNA material CS-RfA-EG (RDB04391) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells.
Human and Animal Cells K562(RCB0027) Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.
Human and Animal Cells K562(RCB0027) , K-562(RCB1635) , K562(RCB1897) Variable characteristics overlooked in human K-562 leukemia cell lines with a common signature.
Human and Animal Cells K562 , THP-1 Dual functions of the C5a receptor as a connector for the K562 erythroblast-like cell-THP-1 macrophage-like cell island and as a sensor for the differentiation of the K562 erythroblast-like cell during haemin-induced erythropoiesis.
Human and Animal Cells HiDEP-1(RCB4554) GAPDH is involved in the heme-maturation of myoglobin and hemoglobin.
Human and Animal Cells HUDEP-2(RCB4557) Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia.
Human and Animal Cells WEHI-3(RCB0035) , Ba/F3(RCB0805) Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
Human and Animal Cells K562 Changes in NAD content induced by nicotinic acid-related compounds in K562 cells during differentiation.
Human and Animal Cells K562 Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia.
Human and Animal Cells HL60(RCB0041) , MOLT-4(RCB0206) , Jurkat(RCB0806) , KU812(RCB0495) , U-937 DE-4(RCB0435) , RAJI(RCB1647) Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy.
Human and Animal Cells K562 Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice.
Human and Animal Cells Ba/F3(RCB0805) Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 Cells.
Human and Animal Cells K562 A bis-pyridinium fullerene derivative induces apoptosis through the generation of ROS in BCR-ABL-positive leukemia cells.
Human and Animal Cells K562(RCB0027) Comprehensive transcriptome analysis of erythroid differentiation potential of olive leaf in haematopoietic stem cells.
Human and Animal Cells K552 Antibody-guided design and identification of CD25-binding small antibody mimetics using mammalian cell surface display.
Human and Animal Cells K562 The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death.